1H-Imidazole-2-methanamine,4,5-dihydro-N-phenyl-N-(phenylmethyl)-, hydrochloride (1:1) cas no:2508-72-7
Synonyms: 1H-Imidazole-2-methanamine,4,5-dihydro-N-phenyl-N-(phenylmethyl)-, monohydrochloride (9CI);2-Imidazoline,2-[(N-benzylanilino)methyl]-, monohydrochloride (8CI);2-(N-Benzylanilinomethyl)-2-imidazoline hydrochloride;5512M;Antastan;Antasten;Antazoline chloride;Antihistal;Antistin;Antistina;Antistine hydrochloride;Azalone;Ben-a-hist;Dibistin;Fenazolina;Histazine;Histostab;Imidamine;Phenazoline hydrochloride;
Name1H-Imidazole-2-methanamine,4,5-dihydro-N-phenyl-N-(phenylmethyl)-, hydrochloride (1:1)
CAS2508-72-7
Synonyms1H-Imidazole-2-methanamine,4,5-dihydro-N-phenyl-N-(phenylmethyl)-, monohydrochloride (9CI);2-Imidazoline,2-[(N-benzylanilino)methyl]-, monohydrochloride (8CI);2-(N-Benzylanilinomethyl)-2-imidazoline hydrochloride;5512M;Antastan;Antasten;Antazoline chloride;Antihistal;Antistin;Antistina;Antistine hydrochloride;Azalone;Ben-a-hist;Dibistin;Fenazolina;Histazine;Histostab;Imidamine;Phenazoline hydrochloride;
EINECS(EC#)219-719-8
Molecular FormulaC17H19N3 .HCl
Molecular Weight265.35286
AppearanceWhite or almost white crystalline powder
storage tempStore at RT
Hazard Xi:Irritant;
Risk R20/21/22;R36/37/38
Safety
Hazard Codes: Xn.gif)
,Xi
Risk Statements:
20: Harmful by inhalation
21: Harmful in contact with skin
22: Harmful if swallowed
36: Irritating to the eyes
37: Irritating to the respiratory system
38: Irritating to the skin
Safety Statements:
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| dog |
LD50 |
intravenous |
30mg/kg (30mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: IRRITABILITY
GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS |
Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 10, Pg. 338, 1951. |
| guinea pig |
LD50 |
intravenous |
17100ug/kg (17.1mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 113, Pg. 313, 1958. |
